Astragaloside IV improves MASLD via GCN5-LXRα/SREBP1c signaling pathway-mediated hepatic de novo lipogenesis
Hui-Mei Liang, Yin-Yue Xu, Kun Miao, Hai-Tao Xiao, Yong-Dan Wang, Jing Jin, He Wu, Bao-Yi Chen, Li-Jun Xu, Jiang-Ping Zhu, Li-Na Lai, Zu-Guo Zheng · 2026
Read Astragaloside IV improves MASLD via GCN5-LXRα/SREBP1c signaling pathway-mediated hepatic de novo lipogenesis by Hui-Mei Liang, Yin-Yue Xu, Kun Miao, Hai-Tao Xiao, Yong-Dan Wang, Jing Jin, He Wu, Bao-Yi Chen, Li-Jun Xu, Jiang-Ping Zhu, Li-Na Lai, Zu-Guo Zheng (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/PMC13617935.txt.
Description
Hui-Mei Liang and eleven colleagues trace how astragaloside IV, a saponin from the herb Astragalus membranaceus, fights fatty liver disease in mice and liver cells. The disease, now called metabolic dysfunction-associated steatotic liver disease, builds fat in the liver alongside obesity and insulin problems, and few drug options exist. The team fed mice a high-fat diet and loaded liver cells with lipids to model the condition.
The compound cut liver fat by suppressing SREBP-1c, a master switch for making new fat. It did so epigenetically: it lowered an enzyme, GCN5, that loosens DNA packaging, reducing chemical marks at the switch's promoter and weakening a partner protein's drive on it. Forcing GCN5 back up erased the compound's benefits, confirming the pathway. The authors highlight an angle for natural product treatment, in which one molecule rewires the liver's fat-making program at the level of gene regulation.
Catalog record
| CREATOR | Hui-Mei Liang, Yin-Yue Xu, Kun Miao, Hai-Tao Xiao, Yong-Dan Wang, Jing Jin, He Wu, Bao-Yi Chen, Li-Jun Xu, Jiang-Ping Zhu, Li-Na Lai, Zu-Guo Zheng |
|---|---|
| YEAR | 2026 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 54 KB |
| LICENSE | https://creativecommons.org/licenses/by/4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |